16-2090261-T-TC
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001009944.3(PKD1):c.12444+23dupG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,607,020 control chromosomes in the GnomAD database, including 146 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 4 hom., cov: 34)
Exomes 𝑓: 0.012 ( 142 hom. )
Consequence
PKD1
NM_001009944.3 intron
NM_001009944.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0930
Publications
1 publications found
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
MIR1225 (HGNC:33931): (microRNA 1225) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 16-2090261-T-TC is Benign according to our data. Variant chr16-2090261-T-TC is described in ClinVar as [Benign]. Clinvar id is 976801.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00764 (1156/151254) while in subpopulation NFE AF = 0.0135 (913/67792). AF 95% confidence interval is 0.0127. There are 4 homozygotes in GnomAd4. There are 525 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.12444+23dupG | intron_variant | Intron 45 of 45 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.12444+23dupG | intron_variant | Intron 45 of 45 | 1 | NM_001009944.3 | ENSP00000262304.4 | |||
PKD1 | ENST00000423118.5 | c.12441+23dupG | intron_variant | Intron 45 of 45 | 1 | ENSP00000399501.1 | ||||
MIR1225 | ENST00000408729.1 | n.23dupG | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
PKD1 | ENST00000472577.1 | n.472+23dupG | intron_variant | Intron 2 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00765 AC: 1156AN: 151140Hom.: 4 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
1156
AN:
151140
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00779 AC: 1877AN: 241054 AF XY: 0.00753 show subpopulations
GnomAD2 exomes
AF:
AC:
1877
AN:
241054
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0121 AC: 17662AN: 1455766Hom.: 142 Cov.: 34 AF XY: 0.0117 AC XY: 8499AN XY: 723476 show subpopulations
GnomAD4 exome
AF:
AC:
17662
AN:
1455766
Hom.:
Cov.:
34
AF XY:
AC XY:
8499
AN XY:
723476
show subpopulations
African (AFR)
AF:
AC:
68
AN:
33352
American (AMR)
AF:
AC:
154
AN:
44320
Ashkenazi Jewish (ASJ)
AF:
AC:
24
AN:
25904
East Asian (EAS)
AF:
AC:
2
AN:
39598
South Asian (SAS)
AF:
AC:
74
AN:
85860
European-Finnish (FIN)
AF:
AC:
469
AN:
51818
Middle Eastern (MID)
AF:
AC:
4
AN:
5752
European-Non Finnish (NFE)
AF:
AC:
16292
AN:
1109070
Other (OTH)
AF:
AC:
575
AN:
60092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1018
2035
3053
4070
5088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00764 AC: 1156AN: 151254Hom.: 4 Cov.: 34 AF XY: 0.00711 AC XY: 525AN XY: 73868 show subpopulations
GnomAD4 genome
AF:
AC:
1156
AN:
151254
Hom.:
Cov.:
34
AF XY:
AC XY:
525
AN XY:
73868
show subpopulations
African (AFR)
AF:
AC:
132
AN:
41108
American (AMR)
AF:
AC:
29
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3462
East Asian (EAS)
AF:
AC:
0
AN:
5092
South Asian (SAS)
AF:
AC:
3
AN:
4790
European-Finnish (FIN)
AF:
AC:
62
AN:
10494
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
913
AN:
67792
Other (OTH)
AF:
AC:
9
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
58
116
175
233
291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal dominant polycystic kidney disease Benign:2
Jan 01, 2019
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research
- -
May 11, 2020
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
MIR1225: BS1, BS2; PKD1: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.